바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기



Physician Directory

HOME > Hospitals > Severance Hospital > Departments > Endocrinology and Metabolism > Physician Directory

Information of doctor

Go list

Cheolryong Ku
doctor's information
Name Cheolryong Ku
Department
Major
Homepage
Blog

Research

  • Extracapsular en bloc resection in pituitary adenoma surgery
    PITUITARY 18/3 :397-404,2015
  • GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
    MEDICINE 94/25 :e998-,2015
  • Association Between Obesity and BRAFV600E Mutation Status in Patients with Papillary Thyroid Cancer
    ANNALS OF SURGICAL ONCOLOGY 22/Suppl :683-690,2015
  • Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in α-cells of mouse pancreatic islets.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 460/3 :616-621,2015
  • Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases
    MEDICINE 95/14 :e3346-,2016
  • No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
    MEDICINE 95/24 :e3,808-,2016
  • The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes
    대한내분비학회지 31/2 :328-335,2016
  • Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy
    DIABETES 66/2 :385-391,2017
  • Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas
    ENDOCRINE 58/1 :184-189,2017
  • Postoperative Gamma Knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas
    WORLD NEUROSURGERY 110/ :534-545,2018
  • Olfactory marker protein regulates prolactin secretion and production by modulating Ca2+ and TRH signaling in lactotrophs
    EXPERIMENTAL AND MOLECULAR MEDICINE 50/4 :15-25,2018
  • A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer
    CANCER LETTERS 417/ :131-140,2018
  • Age- and Sex-Specific Differences as Predictors of Surgical Remission Among Patients With Acromegaly
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 103/3 :909-916,2018
  • Comparative assessment of Graves' disease and main extrathyroidal manifestation, Graves' ophthalmopathy, by non-targeted metabolite profiling of blood and orbital tissue
    SCIENTIFIC REPORTS 8/1 :9,262-9,273,2018
  • Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
    WORLD NEUROSURGERY 115/ :e464-e471,2018
  • Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults
    EUROPEAN JOURNAL OF ENDOCRINOLOGY 179/3 :169-179,2018
  • Lipidomic differentiation of Graves’ ophthalmopathy in plasma and urine from Graves’ disease patients
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY 410/27 :7121-7133,2018
  • Outcomes of Aggressive Surgical Resection in Growth Hormone-Secreting Pituitary Adenomas with Cavernous Sinus Invasion
    WORLD NEUROSURGERY 117/ :280-289,2018
  • Changes of computed tomography-based body composition after adrenalectomy in patients with endogenous hypercortisolism
    CLINICAL ENDOCRINOLOGY 90/2 :267-276,2019
  • Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
    Endocrinology and Metabolism 34/1 :53-62,2019
  • Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
    Journal of Clinical Medicine 8/8 :E1142-,2019
  • Clinical Significance of Radical Surgery in the Treatment of Silent Corticotroph Adenoma
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY 62/1 :114-122,2019

콘텐츠 처음으로 이동